# Placebo Controlled Trial of Bosentan in Scleroderma Patients

> **NCT00377455** · PHASE2 · TERMINATED · sponsor: **Georgetown University** · enrollment: 5 (actual)

## Conditions studied

- Systemic Scleroderma
- Pulmonary Hypertension

## Interventions

- **DRUG:** Bosentan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00377455
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2009-09
- **Final completion:** 2010-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Study was terminated due to inadequate enrolment
- **Last updated:** 2018-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377455, "Placebo Controlled Trial of Bosentan in Scleroderma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00377455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*